Chronic Hepatitis News

Researchers identified four patients with a novel hepatitis C genotype, according to study published in The Journal of Infectious Diseases.

Novel point-of-care hepatitis C tests have advanced the potential for same-day viral diagnosis, which could significantly contribute to global elimination efforts by reaching difficult-to-engage populations such as homeless individuals, people who inject drugs, and individuals in low- or middle-income settings.

The opioid epidemic in the United States has affected millions, exposing them to health risks that include a range of infectious diseases.

In patients with chronic hepatitis B infection, treatment with tenofovir disoproxil may significantly reduce the risk for hepatocellular carcinoma, according to study findings published in The Journal of Infectious Diseases.

Medication nonadherence among patients with hepatitis B increased the risk for hepatocellular carcinoma, cirrhotic complications and all-cause mortality, according to recently published data.

Researchers were able to establish an etiologic diagnosis among nearly 50% of patients with previously indeterminate etiology of acute liver failure using a systematic analysis strategy that included diagnostic algorithms and expert opinion.

Magnetic resonance elastography had significantly higher diagnostic accuracy in staging fibrosis compared with transient elastography among patients with biopsy-proven nonalcoholic fatty liver disease, according to a recently published study.

The Biocodex Microbiota Foundation recently awarded 200,000 euros to Bernd Schnabl, MD, a professor from University of California, San Diego, to advance research on the correlation between gut microbiota and alcoholic hepatitis, according to a press release.

Assembly Bioscience announced the initiation of two randomized control phase 2a trials for ABI-H0731, the company’s lead hepatitis B core inhibitor, according to a press release.

Kidney transplant with a kidney infected with hepatitis C virus, followed by treatment for the hepatitis C, was effective and reduced costs compared with transplant with an uninfected kidney after hepatitis C treatment, according to new research published in Annals of Internal Medicine.